The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Phase II study of sitravatinib in combination with nivolumab in patients undergoing nephrectomy for locally-advanced clear cell renal cell carcinoma (ccRCC).

Jose A.  Karam

Honoraria - EMD Serono; Novartis; Pfizer; Roche/Genentech

Consulting or Advisory Role - EMD Serono; Novartis; Pfizer; Roche/Genentech

Research Funding - Mirati Therapeutics (Inst); Roche/Genentech (Inst)

Travel, Accommodations, Expenses - Novartis; Pfizer; Roche/Genentech